The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
isopropyl 4-[6-(4-{[(2-fluoroethyl)carbamoyl]amino}phenyl)-4-morpholin-4-yl-1Hpyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate ID: ALA1094981
PubChem CID: 44605426
Max Phase: Preclinical
Molecular Formula: C27H35FN8O4
Molecular Weight: 554.63
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)OC(=O)N1CCC(n2ncc3c(N4CCOCC4)nc(-c4ccc(NC(=O)NCCF)cc4)nc32)CC1
Standard InChI: InChI=1S/C27H35FN8O4/c1-18(2)40-27(38)35-11-7-21(8-12-35)36-25-22(17-30-36)24(34-13-15-39-16-14-34)32-23(33-25)19-3-5-20(6-4-19)31-26(37)29-10-9-28/h3-6,17-18,21H,7-16H2,1-2H3,(H2,29,31,37)
Standard InChI Key: WQJYOLLPRXNMCU-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 44 0 0 0 0 0 0 0 0999 V2000
1.1902 -0.1541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1891 -0.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9039 -1.3944 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9021 0.2586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6175 -0.1505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6224 -0.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4142 -1.2337 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8988 -0.5585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4063 0.1109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4762 -1.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2382 -0.9789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2345 -2.6290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4769 -2.2153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8996 1.0836 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6108 1.4953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6103 2.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8965 2.7309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1814 2.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1802 1.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8208 -1.9458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4045 -2.6536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8104 -3.3652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6313 -3.3695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0446 -2.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6363 -1.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9536 -2.2161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9554 -1.3920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0414 -4.0854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6672 -2.6302 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3826 -2.2193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3845 -1.3943 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.0961 -2.6335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8115 -2.2226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6264 -4.7985 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8664 -4.0883 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2764 -4.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5250 -2.6367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2405 -2.2259 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1014 -4.8070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8614 -5.5172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16 17 1 0
17 18 1 0
18 19 1 0
9 5 1 0
7 20 1 0
4 1 1 0
20 21 1 0
5 6 1 0
21 22 1 0
10 11 2 0
22 23 1 0
11 27 1 0
23 24 1 0
24 25 1 0
25 20 1 0
26 27 2 0
26 12 1 0
2 3 1 0
12 13 2 0
23 28 1 0
13 10 1 0
26 29 1 0
2 10 1 0
29 30 1 0
3 6 2 0
30 31 2 0
4 14 1 0
30 32 1 0
14 15 1 0
32 33 1 0
1 2 2 0
28 34 2 0
5 4 2 0
28 35 1 0
6 7 1 0
35 36 1 0
7 8 1 0
33 37 1 0
8 9 2 0
37 38 1 0
14 19 1 0
36 39 1 0
15 16 1 0
36 40 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 554.63Molecular Weight (Monoisotopic): 554.2765AlogP: 3.60#Rotatable Bonds: 7Polar Surface Area: 126.74Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.01CX Basic pKa: 4.01CX LogP: 2.92CX LogD: 2.92Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.45Np Likeness Score: -2.00
References 1. Verheijen JC, Richard DJ, Curran K, Kaplan J, Lefever M, Nowak P, Malwitz DJ, Brooijmans N, Toral-Barza L, Zhang WG, Lucas J, Hollander I, Ayral-Kaloustian S, Mansour TS, Yu K, Zask A.. (2009) Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent., 52 (24): [PMID:19894727 ] [10.1021/jm9013828 ]